Table 3.
Clinicopathological characteristics | SEMA5A expression | P value | |
---|---|---|---|
Low (n = 109) | High (n = 123) | ||
Age (years) | |||
≤ 45 | 47 | 60 | 0.388 |
> 45 | 62 | 63 | |
FIGO stage | |||
Ia | 9 | 3 | 0.019a |
Ib | 44 | 35 | |
IIa | 32 | 55 | |
IIb | 24 | 30 | |
Tumor grade | |||
High | 28 | 19 | 0.090 |
Intermediate | 49 | 55 | |
Low | 32 | 49 | |
Histological type | |||
Squamous carcinoma | 76 | 80 | 0.262 |
Adenocarcinoma | 29 | 32 | |
Adenosquamous carcinoma | 4 | 11 | |
Lymphatic permeation | |||
No | 96 | 94 | 0.021a |
Yes | 13 | 29 | |
VEGF-C expression | |||
High | 19 | 101 | < 0.001a |
Low | 90 | 22 | |
Lymphatic microvessel density | |||
High | 23 | 92 | < 0.001a |
Low | 86 | 31 | |
Lymph node metastasis | |||
No | 68 | 43 | < 0.001a |
Yes | 41 | 80 |
FIGO Federation of Gynecology and Obstetrics, SEMA5A semaphorin 5A, VEGF-C vascular endothelial growth factor-C
aChi square test P < 0.05